SKYEPHARMA PLC |
End-of-day quote
Other stock markets
|
||
| - GBX | - |
|
| 2016 | GlaxoSmithKline : Vectura to buy SkyePharma for 441 million pounds as UK biotech consolidates | RE |
| 2016 | Skyepharma : estimates full-year revenue ahead of its expectations | RE |
Share class
| Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
|---|---|---|---|---|---|
| Stock A | 1 | 105,912,259 | 0 | 0 | - |
Company contact information
Sector
| 1st Jan change | Capi. | |
|---|---|---|
| +25.49% | 672B | |
| +25.87% | 570B | |
| -5.92% | 360B | |
| +16.06% | 321B | |
| +8.54% | 300B | |
| +7.14% | 217B | |
| -9.12% | 204B | |
| +5.10% | 199B | |
| -9.10% | 149B |
- Stock Market
- Equities
- Stock
- Company SkyePharma PLC
